Publicacions en què col·labora amb David Sancho Madrid (6)

2022

  1. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

    Cancer research, Vol. 82, Núm. 23, pp. 4373-4385

2019

  1. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 7, Núm. 1

2018

  1. Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated t-cell cross-priming

    Cancer Research, Vol. 78, Núm. 23, pp. 6643-6654

  2. Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation

    Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811

2017

  1. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy

    Annals of Oncology, Vol. 28, pp. xii44-xii55

  2. Corrigendum: Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy [Ann Oncol, 28, Suppl 12, (2017)] DOI:10.1093/annonc/mdx237

    Annals of Oncology